This cross-sectional study examines electronic health record data from the All of Us Research Program to measure prevalence, correlates, and overlap between psychiatric disorders.
Key Points
Question
What are the prevalence, correlates, and overlap between psychiatric disorders reported in the All of Us Research Program?
Findings
In this cross-sectional study, the prevalence of diagnosed psychiatric disorders ranged from approximately 1% to 11% with personality disorders being the least common and mood disorders being the most common. Associations across sociodemographic factors recapitulated previous epidemiological research.
Meaning
While the prevalence of psychiatric disorders in All of Us was lower than population estimates, the patterns across disorders and sociodemographic characteristics were congruent with prior research.
Abstract
Importance
All of Us is a landmark initiative for population-scale research into a variety of health conditions, including psychiatric disorders.
Objective
To analyze the prevalence, comorbidity, and sociodemographic covariates of psychiatric disorders in the All of Us biobank.
Design, Setting, and Participants
We estimated prevalence, overlap, and sociodemographic correlates for psychiatric disorders as reported in electronic health records for All of Us release 5 (N = 331 380).
Exposures
Social and demographic covariates.
Main Outcomes and Measures
Psychiatric disorders derived from International Statistical Classification of Diseases, Tenth Revision, Clinical Modification, codes across 6 broad domains: mood disorders, anxiety disorders, substance use disorders, stress-related disorders, schizophrenia, and personality disorders.
Results
The analytic sample (N = 329 038) was 60.7% female (mean [SD] age, 50.9 [16.8] years). The prevalence of disorders ranged from 11.00% (95% CI, 10.68% to 11.32%) for any mood disorder to less than 1% (eg, obsessive-compulsive disorder, 0.18%; 95% CI, −0.16% to 0.52%), with mood disorders being the most common and personality disorders being the least. There was substantial overlap among disorders, with the majority of participants with a disorder (30 113/58 806, approximately 51%) having 2 or more registered diagnoses and tetrachoric correlations ranging from 0.43 to 0.74. Comparisons of prevalence across demographic categories revealed that non-Hispanic White people, individuals with low socioeconomic status, women and individuals assigned female at birth, and sexual minority individuals are at greatest risk for most disorders.
Conclusions and Relevance
Although rates of disorders among the All of Us cohort are lower than in the general population, considerable variation, comorbidity, and disparities exist across social groups. To improve the practice of equitable precision medicine, researchers can use comprehensive health data from large-scale resources such as All of Us.
Introduction
Psychiatric disorders pose a significant burden to public health. Conditions such as depression, anxiety, and substance use disorders are leading contributors to the national burden of disease.1 Importantly, these disorders rarely manifest in isolation, showing strong patterns of comorbidity.2
To improve diversity in health research, interrogate health disparities, and deliver on the promise of equitable precision medicine, the National Institutes of Health launched the All of Us program, a historic effort to collect and study data from at least 1 million people living in the United States.3 Beginning in 2018, participants could complete surveys, provide genotypic data, and link their electronic health records (EHRs) to help build a comprehensive database. The goal of the All of Us program is to better understand how biology, lifestyle, and social determinants come together to affect health.
We characterize the prevalence of psychiatric disorders in the All of Us database, comparing estimates with those from nationally representative samples. In addition, we estimate comorbidity across disorders and sociodemographic disparities to help better understand the participants who make up this sample.
Methods
The All of Us Research Program
All of Us is a prospective, nationwide cohort study of the effects of lifestyle, environment, and genomics on health outcomes. Participant recruitment is predominantly done through participating health care organizations and in partnership with Federally Qualified Health Centers. Interested participants can enroll as direct volunteers, visiting community-based enrollment sites. Enrollment, informed consent, and baseline health surveys are done digitally through the All of Us website (https://joinallofus.org).4 Participants are then invited to undergo a basic physical examination and biospecimen collection at an affiliated health care site. Participant follow-up is done in 2 ways, passively via linkage with EHRs and actively by periodic follow-up surveys. We included data from participants enrolled between May 6, 2018, and April 1, 2021 (release 5, N = 331 380). Analyses were conducted in accordance with the All of Us Code of Conduct and the institutional review board of SUNY Downstate. Participants provided informed consent when joining All of Us, including authorizing All of Us to access their EHRs.
Measures
Diagnoses were based on phecodes,5 curated groupings of related billing codes from the International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) (eTable 1 in the Supplement). We selected all relevant ICD-10-CM codes for disorders related to mood, anxiety, substance use, stress, personality, eating, psychotic, and other disorders. Individuals with 2 or more ICD-10-CM codes were considered to have a diagnosis, based on prior EHR analyses.6 Our analyses also included measures for age, sex, gender identity, sexual orientation, race and ethnicity, educational attainment, household income, access to health insurance, and country of origin (eTable 2 and the eAppendix in the Supplement contain a full description). Race and ethnicity data were provided by All of Us, which used a survey asking how participants identify to categorize responses as Asian; Black or African American; Hispanic or Latino, Latina, or Latinx; non-Hispanic White; multiracial; and other race or ethnicity, for identities that did not fit into any of the other categories.
Results
Table 1 presents the prevalence for each disorder. Mood disorders were the most common (11.0%; 95% CI, 10.68%-11.32%), followed by anxiety disorders (10.11%; 95% CI, 9.79%-10.44%), substance use disorders (7.22%; 95% CI, 6.89%-7.54%), and stress-related disorders (2.89%; 95% CI, 2.55%-3.23%). Approximately 1% of participants (1.07%; 95% CI, 0.73%-1.41%) had a documented sleep disorder. Attention-deficit/hyperactivity disorder, schizophrenia, personality disorders, eating disorders, and obsessive-compulsive disorder each had a prevalence at or below 1% (Table 1). The prevalence of each disorder was lower than those from nationally representative samples (prevalence by sociodemographic category is provided in eFigure 1 in the Supplement). When we constrained for more rigorous definitions of being affected (≥3 and ≥4 ICD-10-CM codes), there was a steady decrease in the prevalence (eAppendix, eTable 3, and eFigure 2 in the Supplement).
Table 1. Prevalence of Psychiatric Diagnoses in the All of Us Research Program (N = 329 038).
Phenotype | No. of cases | Prevalence, % (95% CI) | Population prevalence, %a |
---|---|---|---|
Major depressive disorder | 30 544 | 9.28 (8.96 to 9.61) | 16.6 |
Bipolar | 7411 | 2.25 (1.91 to 2.59) | 3.9 |
Dysthymic disorder | 1661 | 0.50 (0.16 to 0.85) | 2.5 |
Any mood disorder | 36 191 | 11.00 (10.68 to 11.32) | 20.8 |
Anxiety disorder (unspecified) | 29 989 | 9.11 (8.79 to 9.44) | |
Generalized anxiety disorder | 8320 | 2.53 (2.19 to 2.87) | 5.7 |
Social anxiety disorder/agoraphobia | 2934 | 0.89 (0.55 to 1.23) | 12.1/1.4 |
Phobia | 406 | 0.12 (−0.22 to 0.46) | 12.5 |
Any anxiety disorder | 33 276 | 10.11 (9.79 to 10.44) | 28.8 |
Alcohol use disorder | 6201 | 1.88 (1.55 to 2.22) | 29.1 |
Tobacco use disorder | 17 272 | 5.25 (4.92 to 5.58) | 17.7 |
Drug use disorder | 9907 | 3.01 (2.67 to 3.35) | 9.9 |
Cannabis | 2823 | 0.86 (0.52 to 1.20) | |
Cocaine | 3326 | 1.01 (0.67 to 1.35) | |
Opioids | 5688 | 1.73 (1.39 to 2.07) | |
Other substances | 6826 | 2.07 (1.74 to 2.41) | |
Any substance use disorder | 23 742 | 7.22 (6.89 to 7.54) | 32.3 |
Adjustment disorder | 4565 | 1.39 (1.05 to 1.73) | |
Posttraumatic stress disorder | 5525 | 1.68 (1.34 to 2.02) | 6.1 |
Any stress-related disorder | 9510 | 2.89 (2.55 to 3.23) | |
Sleep disorder | 3511 | 1.07 (0.73 to 1.41) | 5.6 |
Schizophrenia | 2653 | 0.81 (0.47 to 1.15) | 0.9 |
Attention-deficit/hyperactivity disorder | 2475 | 0.75 (0.41 to 1.09) | 8.1 |
Antisocial personality/borderline personality disorder | 894 | 0.27 (−0.07 to 0.61) | 3.8/2.7 |
Schizotypal personality disorder | 45 | 0.01 (−0.33 to 0.36) | 0.6 |
Any personality disorder | 1497 | 0.45 (0.11 to 0.80) | 0.3 to 2.7 |
Eating disorder, females/males | 559 | 0.17 (−0.17 to 0.51) | 8.4/2.2 |
Obsessive-compulsive disorder | 603 | 0.18 (−0.16 to 0.52) | 1.9 |
Estimates for population prevalence are described in the eAppendix in the Supplement.
The Figure presents the tetrachoric correlations between diagnoses and patterns of comorbidity. We observed significant correlations across all disorders (r = 0.43-0.75). Approximately 51% of the diagnoses (30 113/58 806) involved some overlap. The majority of participants with multiple diagnoses (64%, n = 19 481) had some configuration of mood, anxiety, and substance use disorders. While the frequency of each disorder was lower using more restrictive definitions, the patterns of correlation and comorbidity remained virtually unchanged (eAppendix and eFigures 3 and 4 in the Supplement).
Table 2 presents the adjusted odds ratios (OR) for sociodemographic factors. Men and those assigned male at birth had lower odds of mood and anxiety disorders (from OR, 0.78 [95% CI, 0.68-0.90] to OR, 0.81 [95% CI, 0.71-0.93]), but increased risk for substance use disorders and schizophrenia (from OR, 1.27 [95% CI, 1.09-1.47] to OR, 1.82 [95% CI, 1.25-2.65]). Participants who were lesbian, gay, bisexual, transgender, or queer (LGBTQ) were at increased risk for most disorders (from OR, 1.18 [95% CI, 1.13-1.23] to OR, 1.88 [95% CI, 1.66-2.13]). People from all racial and ethnic categories were at reduced risk for most disorders compared with non-Hispanic White participants (from OR, 0.30 [95% CI, 0.26-0.35] to OR, 0.86 [95% CI, 0.78-0.93]), except for schizophrenia, where participants who were Black or African American, multiracial, or another race and ethnicity were at increased risk (from OR, 1.22 [95% CI, 1.10-1.36] to OR, 1.72 [95% CI, 1.30-2.28]). Participants born outside the United States were at reduced risk for every disorder (OR, 0.36 [95% CI, 0.34-0.38] to OR, 0.67 [95% CI, 0.64-0.70]). Participants from each educational and income category were at lower risk relative to those with less than a high school education or those reporting an annual income less than $25 000, respectively (from OR, 0.04 [95% CI, 0.02-0.07] to OR, 0.88 [95% CI, 0.81-0.96]). Participants from each relationship category were at increased risk relative to those who were married (from OR, 1.10 [95% CI, 1.04-1.15] to OR, 2.47 [95% CI, 2.00-3.04]). Results were similar when using more restrictive definitions of diagnosis (eAppendix and eTables 4 and 5 in the Supplement).
Table 2. Adjusted Estimates of Risk for Psychiatric Disorders.
Any mood disorder | Any anxiety disorder | Any substance use disorder | Any stress-related disorder | Schizophrenia | Any personality disorder | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
aOR (SE)a | 95% CI | aOR (SE)a | 95% CI | aOR (SE)a | 95% CI | aOR (SE)a | 95% CI | aOR (SE)a | 95% CI | aOR (SE)a | 95% CI | |
Sex | ||||||||||||
Female | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Male | 0.81 (0.07)b | 0.71-0.93 | 0.84 (0.07) | 0.73-0.96 | 1.30 (0.08)b | 1.12-1.51 | 0.79 (0.12) | 0.63-0.99 | 1.04 (0.19) | 0.72-1.50 | 0.85 (0.23) | 0.54-1.34 |
Neither selected | 0.98 (0.06) | 0.87-1.09 | 0.98 (0.06) | 0.87-1.11 | 1.22 (0.07)b | 1.07-1.39 | 0.90 (0.10) | 0.74-1.09 | 1.09 (0.18) | 0.77-1.54 | 0.63 (0.28) | 0.36-1.10 |
Gender | ||||||||||||
Woman | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Man | 0.86 (0.07) | 0.76-0.98 | 0.78 (0.07)b | 0.68-0.90 | 1.27 (0.08)b | 1.09-1.47 | 1.14 (0.12) | 0.91-1.44 | 1.82 (0.19)b | 1.25-2.65 | 0.90 (0.24) | 0.56-1.43 |
Neither selected | 1.00 (0.05) | 0.92-1.10 | 0.94 (0.05) | 0.86-1.04 | 1.09 (0.06) | 0.97-1.22 | 1.32 (0.08)b | 1.13-1.53 | 1.58 (0.15)b | 1.18-2.11 | 1.48 (0.16) | 1.08-2.02 |
Sexual orientation | ||||||||||||
Heterosexual | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Other than heterosexual | 1.33 (0.02b | 1.29-1.38 | 1.23 (0.02)b | 1.19-1.27 | 1.18 (0.02)b | 1.13-1.23 | 1.37 (0.03)b | 1.30-1.46 | 1.56 (0.05)b | 1.41-1.72 | 1.88 (0.06)b | 1.66-2.13 |
Age, y | ||||||||||||
18-29 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
30-44 | 1.67 (0.02)b | 1.60-1.74 | 1.53 (0.02)b | 1.46-1.59 | 2.23 (0.03)b | 2.12-2.35 | 1.61 (0.04)b | 1.50-1.74 | 2.39 (0.08)b | 2.06-2.77 | 1.26 (0.08)b | 1.08-1.47 |
45-64 | 1.99 (0.02)b | 1.91-2.08 | 1.51 (0.02)b | 1.45-1.57 | 2.39 (0.03)b | 2.27-2.52 | 1.69 (0.04)b | 1.56-1.82 | 2.44 (0.08)b | 2.10-2.83 | 0.99 (0.08) | 0.85-1.17 |
≥65 | 1.55 (0.02)b | 1.48-1.63 | 1.09 (0.02)b | 1.04-1.14 | 1.23 (0.03)b | 1.16-1.31 | 1.18 (0.04)b | 1.08-1.29 | 1.03 (0.10) | 0.84-1.26 | 0.35 (0.12)b | 0.28-0.44 |
Race and ethnicity | ||||||||||||
Asian | 0.46 (0.05)b | 0.42-0.51 | 0.46 (0.05)b | 0.42-0.51 | 0.42 (0.09)b | 0.35-0.50 | 0.62 (0.09)b | 0.52-0.74 | 0.56 (0.29) | 0.32-0.98 | 0.28 (0.32)b | 0.15-0.52 |
Black and African American | 0.51 (0.02)b | 0.50-0.53 | 0.41 (0.02)b | 0.39-0.42 | 0.67 (0.02)b | 0.65-0.69 | 0.66 (0.03)b | 0.62-0.70 | 1.22 (0.05)b | 1.10-1.36 | 0.30 (0.08)b | 0.26-0.35 |
Hispanic or Latino | 0.74 (0.02)b | 0.71-0.77 | 0.69 (0.02)b | 0.66-0.71 | 0.77 (0.02)b | 0.73-0.81 | 0.76 (0.04)b | 0.71-0.82 | 1.13 (0.07) | 0.98-1.30 | 0.47 (0.09)b | 0.39-0.55 |
Non-Hispanic White | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Multiracial | 0.89 (0.05) | 0.82-0.98 | 0.82 (0.05)b | 0.75-0.90 | 1.01 (0.06) | 0.90-1.12 | 1.04 (0.08) | 0.89-1.21 | 1.72 (0.14)b | 1.30-2.28 | 0.92 (0.17) | 0.66-1.27 |
Not reported | 0.85 (0.04)b | 0.78-0.92 | 0.80 (0.04)b | 0.74-0.87 | 1.00 (0.05) | 0.91-1.09 | 0.89 (0.08) | 0.77-1.04 | 1.55 (0.12)b | 1.23-1.95 | 0.67 (0.18) | 0.47-0.95 |
Other race and ethnicity | 0.92 (0.04) | 0.84-1.00 | 0.86 (0.04)b | 0.78-0.93 | 1.09 (0.05) | 0.99-1.21 | 1.07 (0.08) | 0.92-1.24 | 1.52 (0.14)b | 1.16-1.99 | 0.83 (0.18) | 0.59-1.18 |
Country of origin | ||||||||||||
US born | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Not US born | 0.67 (0.02)b | 0.64-0.70 | 0.61 (0.02)b | 0.58-0.64 | 0.36 (0.03)b | 0.34-0.38 | 0.62 (0.04)b | 0.57-0.67 | 0.46 (0.09)b | 0.38-0.55 | 0.50 (0.12)b | 0.40-0.64 |
Not reported | 0.94 (0.06) | 0.84-1.05 | 0.91 (0.06) | 0.81-1.02 | 1.09 (0.06) | 0.97-1.22 | 0.90 (0.10) | 0.73-1.10 | 1.12 (0.14) | 0.84-1.48 | 0.93 (0.25) | 0.57-1.51 |
Education | ||||||||||||
Less than HS | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
HS diploma or equivalent | 0.95 (0.02) | 0.91-0.99 | 0.97 (0.02) | 0.93-1.02 | 0.84 (0.02)b | 0.80-0.87 | 1.05 (0.04) | 0.97-1.13 | 0.79 (0.05)b | 0.71-0.88 | 0.86 (0.09) | 0.72-1.03 |
Some college | 0.95 (0.02) | 0.91-0.99 | 0.98 (0.02) | 0.94-1.03 | 0.66 (0.02)b | 0.63-0.69 | 1.06 (0.04) | 0.99-1.15 | 0.58 (0.06)b | 0.51-0.65 | 0.97 (0.09) | 0.81-1.16 |
College degree or higher | 0.67 (0.02)b | 0.64-0.70 | 0.71 (0.02)b | 0.68-0.75 | 0.26 (0.03)b | 0.25-0.28 | 0.78 (0.04)b | 0.72-0.85 | 0.36 (0.08)b | 0.30-0.42 | 0.52 (0.11)b | 0.42-0.64 |
Not reported | 0.88 (0.04)b | 0.81-0.96 | 0.84 (0.05)b | 0.76-0.92 | 0.90 (0.04) | 0.83-0.98 | 0.85 (0.08) | 0.73-0.99 | 0.81 (0.10) | 0.66-0.99 | 0.90 (0.19) | 0.62-1.29 |
Income, $/y | ||||||||||||
<25 000 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
25 000-50 000 | 0.67 (0.02)b | 0.65-0.69 | 0.74 (0.02)b | 0.71-0.77 | 0.56 (0.02)b | 0.54-0.59 | 0.68 (0.03)b | 0.63-0.72 | 0.36 (0.08)b | 0.31-0.43 | 0.49 (0.08)b | 0.41-0.57 |
50 000-75 000 | 0.54 (0.02)b | 0.52-0.56 | 0.61 (0.02)b | 0.59-0.64 | 0.36 (0.03)b | 0.33-0.38 | 0.59 (0.04)b | 0.55-0.64 | 0.16 (0.15)b | 0.12-0.22 | 0.33 (0.12)b | 0.26-0.42 |
75 000-100 000 | 0.45 (0.03)b | 0.43-0.47 | 0.54 (0.03)b | 0.51-0.57 | 0.29 (0.04)b | 0.26-0.31 | 0.46 (0.05)b | 0.41-0.50 | 0.10 (0.24)b | 0.06-0.15 | 0.26 (0.16)b | 0.19-0.35 |
>100 000 | 0.33 (0.02)b | 0.31-0.34 | 0.40 (0.02)b | 0.39-0.42 | 0.18 (0.04)b | 0.17-0.20 | 0.36 (0.04)b | 0.33-0.40 | 0.04 (0.26)b | 0.02-0.07 | 0.12 (0.16)b | 0.09-0.16 |
Not reported | 0.68 (0.02)b | 0.66-0.70 | 0.73 (0.02)b | 0.71-0.76 | 0.72 (0.02)b | 0.69-0.75 | 0.71 (0.03)b | 0.67-0.76 | 0.74 (0.05)b | 0.68-0.82 | 0.66 (0.07)b | 0.57-0.76 |
Health insurance | ||||||||||||
Has | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Does not have | 0.41 (0.03)b | 0.39-0.44 | 0.40 (0.03)b | 0.38-0.43 | 0.41 (0.03)b | 0.38-0.43 | 0.53 (0.05)b | 0.48-0.58 | 0.28 (0.09)b | 0.24-0.34 | 0.55 (0.11)b | 0.44-0.68 |
Not reported | 0.69 (0.04)b | 0.64-0.74 | 0.67 (0.04)b | 0.62-0.73 | 0.76 (0.04)b | 0.71-0.82 | 0.72 (0.07)b | 0.63-0.83 | 0.69 (0.10)b | 0.56-0.83 | 0.57 (0.18)b | 0.40-0.81 |
Marital information | ||||||||||||
Married | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||||
Cohabiting | 1.13 (0.03)b | 1.08-1.19 | 1.10 (0.03)b | 1.04-1.15 | 1.85 (0.03)b | 1.74-1.97 | 1.14 (0.05)b | 1.04-1.25 | 1.59 (0.10)b | 1.30-1.95 | 1.24 (0.12) | 0.99-1.56 |
Divorced | 1.41 (0.02)b | 1.36-1.46 | 1.29 (0.02)b | 1.25-1.34 | 1.88 (0.02)b | 1.80-1.97 | 1.48 (0.03)b | 1.39-1.58 | 2.08 (0.08)b | 1.79-2.43 | 2.00 (0.09)b | 1.69-2.37 |
Never married | 1.24 (0.02)b | 1.20-1.29 | 1.10 (0.02)b | 1.06-1.14 | 1.70 (0.02)b | 1.63-1.78 | 1.17 (0.03)b | 1.10-1.25 | 2.46 (0.07)b | 2.12-2.84 | 1.55 (0.09)b | 1.31-1.83 |
Separated | 1.40 (0.03)b | 1.32-1.48 | 1.24 (0.03)b | 1.16-1.32 | 1.93 (0.03)b | 1.81-2.06 | 1.40 (0.05)b | 1.26-1.55 | 2.09 (0.10)b | 1.72-2.54 | 1.87 (0.13)b | 1.45-2.41 |
Widowed | 1.32 (0.03)b | 1.26-1.39 | 1.17 (0.03)b | 1.11-1.24 | 1.73 (0.03)b | 1.61-1.85 | 1.47 (0.05)b | 1.34-1.61 | 1.90 (0.11)b | 1.52-2.37 | 1.38 (0.15) | 1.03-1.86 |
Not reported | 1.22 (0.04)b | 1.13-1.31 | 1.15 (0.04)b | 1.06-1.24 | 1.76 (0.04)b | 1.62-1.90 | 1.36 (0.06)b | 1.20-1.55 | 2.47 (0.11)b | 2.00-3.04 | 2.00 (0.15)b | 1.50-2.66 |
Abbreviations: aOR, adjusted odds ratio; HS, high school.
All estimates conditional on all other covariates included in the model.
P < .05 ÷ 6 = .008.
Discussion
We explored psychiatric disorders in the All of Us research program, examining prevalence, comorbidity, and sociodemographic disparities and how they vary across ICD-10-CM thresholds for defining who is affected. Other biobanks have a well-known “healthy participant” bias.7 This bias is apparent in All of Us given that disorders captured in the EHR occur at lower frequency than estimates from nationally representative samples.2,8 In addition, the positive association between health insurance and each disorder suggests some barrier to health care for participants without insurance, similar to prior research.9 Diagnoses were strongly intercorrelated, supporting the idea that psychiatric disorders may in part share common causes.10 Most respondents with any registered diagnosis had diagnoses for 2 or more disorders in their EHR. The most common configuration of overlap involved mood, anxiety, and substance use disorders. These patterns of comorbidity remained consistent, even for more restrictive definitions.
Disparities across sociodemographic factors were similar to disparities from nationally representative samples.2 Participants who were assigned female at birth, women, and LGBTQ individuals were at increased risk of most disorders.8 People from every racial and ethnic category were at reduced risk of most disorders, relative to non-Hispanic White participants, a commonly observed pattern that is in the opposite direction of physical health disparities.11 One exception was the increased risk of schizophrenia for Black and African American, multiracial, and other non-White participants, which has previously been attributed as a consequence of racism12 and bias in the diagnosis.13 Further, participants with a college degree and annual household incomes more than $100 000 were at the lowest risk for each disorder, which could reflect processes of social causation14 or social selection or drift.15 Again, these patterns remained consistent regardless of the number of ICD-10-CM codes required for diagnosis.
Limitations
Our analysis has several limitations. We focused on participants with any documented history of disorders. Our measures of diagnosis could be biased in that (1) they are limited to those who have sought treatment and (2) they could reflect misdiagnosis given that they require only 2 records in the EHR. Sensitivity analyses using more stringent thresholds resulted in a lower estimated prevalence for each disorder. Future work can leverage available genetic data in All of Us to examine whether there are distinct causes across different thresholds for inclusion.
Conclusions
The goal of the All of Us program is to create a resource for medical research in the United States, with an emphasis in improving health equity and representation. In the current analysis, we investigated the available data on psychiatric disorders. Although the rates of disorders in the All of Us cohort were lower than in the general population, considerable variation, comorbidity, and disparities existed across social groups. Future research can draw on the vast genetic, lifestyle, and other social data to investigate the causes and consequences of psychiatric conditions.
References
- 1.US Burden of Disease Collaborators; Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444-1472. doi: 10.1001/jama.2018.0158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol. 2015;50(11):1609-1640. doi: 10.1007/s00127-015-1088-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Denny JC, Rutter JL, Goldstein DB, et al. ; All of Us Research Program Investigators . The “All of Us” Research Program. N Engl J Med. 2019;381(7):668-676. doi: 10.1056/NEJMsr1809937 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.National Institutes of Health . All of Us Research Program. US Department of Health and Human Services. Published 2021. https://allofus.nih.gov/
- 5.Denny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013;31(12):1102-1110. doi: 10.1038/nbt.2749 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zheutlin AB, Dennis J, Karlsson Linnér R, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four health care systems. Am J Psychiatry. 2019;176(10):846-855. doi: 10.1176/appi.ajp.2019.18091085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026-1034. doi: 10.1093/aje/kwx246 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi: 10.1001/archpsyc.62.6.593 [DOI] [PubMed] [Google Scholar]
- 9.Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640. doi: 10.1001/archpsyc.62.6.629 [DOI] [PubMed] [Google Scholar]
- 10.Brainstorm Consortium; Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395):eaap8757. doi: 10.1126/science.aap8757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Williams DR, Sternthal M. Understanding racial-ethnic disparities in health: sociological contributions. J Health Soc Behav. 2010;51 Suppl(suppl):S15-27. doi: 10.1177/0022146510383838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schwartz RC, Blankenship DM. Racial disparities in psychotic disorder diagnosis: A review of empirical literature. World J Psychiatry. 2014;4(4):133-140. doi: 10.5498/wjp.v4.i4.133 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Metzl JM. The Protest Psychosis: How Schizophrenia Became a Black Disease. Beacon Press; 2010. [Google Scholar]
- 14.Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;35(Spec No):80-94. doi: 10.2307/2626958 [DOI] [PubMed] [Google Scholar]
- 15.Breslau J, Lane M, Sampson N, Kessler RC. Mental disorders and subsequent educational attainment in a US national sample. J Psychiatr Res. 2008;42(9):708-716. doi: 10.1016/j.jpsychires.2008.01.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.